Stephanie A. Wagner
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Pancreatic and Hepatic Oncology Research, Ecology and Vegetation Dynamics Studies, Peptidase Inhibition and Analysis, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma(2022)375 cited
- → Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer(2016)320 cited
- → Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed(2015)281 cited
- → Potential Negative Ecological Effects of Corridors(2014)179 cited
- → Rituximab‐induced interstitial lung disease(2007)145 cited
- → Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88- and Syk kinase-dependent pathways(2007)70 cited
- → Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer(2022)58 cited
- → Local‐scale biotic interactions embedded in macroscale climate drivers suggest Eltonian noise hypothesis distribution patterns for an invasive grass(2014)54 cited
- → A randomized double-blind phase 2 study of ruxolitinib (RUX) or placebo (PBO) with capecitabine (CAPE) as second-line therapy in patients (pts) with metastatic pancreatic cancer (mPC).(2014)51 cited
- → Mobilization of Hematopoietic Progenitor Cells by Yeast-Derivedβ-Glucan Requires Activation of Matrix Metalloproteinase-9(2008)38 cited